In one paragraphArticle in Circulation. Heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Hongyang PiDepartment of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle.ORCID 0000-0002-6963-3354 Samuel G RaynerDepartment of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle.ORCID 0000-0002-2541-4221 Sina A GharibDepartment of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle.ORCID 0000-0002-2480-4367 Peter J LearyDepartment of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle.ORCID 0000-0001-5716-248X Funding
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6MIntegrated Multi-omics of MelioidosisR01AI137111 · NIAID · UNIVERSITY OF WASHINGTON · PI GHARIB, SINA A, WEST, TIMOTHY EOIN · 2018 to 2021
$3.2MREHAB-PH Trial: Repurposing a Histamine Antagonist to Benefit Patients with Pulmonary HypertensionR33HL142539 · NHLBI · UNIVERSITY OF WASHINGTON · PI LEARY, PETER J · 2019 to 2022
$2.7MMachine Learning Tools for Discovery and Analysis of Active Metabolic PathwaysR01GM114029 · NIGMS · UNIVERSITY OF WASHINGTON · PI SHOJAIE, ALI · 2016 to 2020
$1.7MNovel Statistical Inference for Biomedical Big DataR01GM133848 · NIGMS · UNIVERSITY OF WASHINGTON · PI SHOJAIE, ALI · 2020 to 2023
$1.7MThe Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) studyR01HL152724 · NHLBI · UNIVERSITY OF WASHINGTON · PI GHARIB, SINA A, LEARY, PETER J · 2020 to 2023
$1.6MProteomic Signatures Associated with Right Ventricular Failure and Mortality in Pulmonary Arterial HypertensionF32HL168780 · NHLBI · UNIVERSITY OF WASHINGTON · PI PI, HONGYANG · 2023 to 2024
$176kNCATS NIH HHS KL2 TR000421NHLBI NIH HHS F32 HL168780NHLBI NIH HHS R01 HL152724NHLBI NIH HHS R33 HL142539NIAID NIH HHS R01 AI137111NIGMS NIH HHS R01 GM114029NIGMS NIH HHS R01 GM133848
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkershumansmetabolomicsmorbiditymortalityprognosisproteomics
Identifiers
PMID40899269
PMCPMC12577545
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390